Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some comfort from ...

Two North Texas men are facing charges after allegedly plotting to invade an island off Haiti, kill all the men and turn the women and children into their sex slaves, according to the U.S. Attorney's ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...